Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Koninklijke Philips Stock Performance
Shares of NYSE:PHG traded down $0.23 during midday trading on Friday, reaching $18.66. The company had a trading volume of 51,662 shares, compared to its average volume of 1,943,956. The company's 50 day moving average price is $20.95 and its 200 day moving average price is $26.45. The company has a current ratio of 1.19, a quick ratio of 0.70 and a debt-to-equity ratio of 0.46. The stock has a market cap of $16.59 billion, a P/E ratio of 4.65, a P/E/G ratio of 1.40 and a beta of 0.91. Koninklijke Philips has a 52-week low of $18.75 and a 52-week high of $48.72.
Analyst Ratings Changes
A number of brokerages have commented on PHG. JPMorgan Chase & Co. decreased their price target on shares of Koninklijke Philips from €21.30 ($21.73) to €18.80 ($19.18) and set an "underweight" rating for the company in a research note on Wednesday, July 27th. Societe Generale lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Monday, July 25th. Barclays decreased their price target on shares of Koninklijke Philips from €45.00 ($45.92) to €39.00 ($39.80) in a research note on Thursday, July 28th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of Koninklijke Philips from €25.00 ($25.51) to €24.00 ($24.49) and set a "hold" rating for the company in a research note on Tuesday, July 5th. Finally, UBS Group reduced their target price on shares of Koninklijke Philips from €17.00 ($17.35) to €16.00 ($16.33) and set a "sell" rating for the company in a research note on Tuesday, July 26th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $25.76.